COMMUNIQUÉS West-GlobeNewswire

Obalon Announces Restructuring to Streamline Operations & Cash Use
03/04/2019
SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon [...]
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the 2019 American Association for Cancer Research (AACR) Annual Meeting
03/04/2019
Preclinical data supports the development of JTX-8064 as a novel immunotherapy to reprogram immune-suppressive macrophages and enhance anti-tumor immunity CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Jounce [...]
Evelo Biosciences to Present at 18th Annual Needham Healthcare Conference
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing monoclonal microbials, a potential new modality of oral biologic [...]
Soleno Therapeutics to Present at the 2019 H.C. Wainwright Global Life Sciences Conference
03/04/2019
REDWOOD CITY, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
GBT Announces New Employment Inducement Grants
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on April 1, 2019, the compensation committee of GBT’s board of directors granted [...]
Kezar Life Sciences to Present at the 18th Annual Needham Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet [...]
Opiant Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Data Supporting Potential of OPNT002, Nasal Naltrexone, for Treatment of Alcohol Use Disorder
03/04/2019
Data published online in The Journal of Clinical Pharmacology SANTA MONICA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT), a specialty pharmaceutical company developing medicines [...]
Shockwave Completes Enrollment of Disrupt CAD II Study
03/04/2019
European Post-Market Study to Demonstrate Ongoing Safety of Coronary Intravascular Lithotripsy SANTA CLARA, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development [...]
Catalyst Biosciences to Present at The Needham & Company 18th Annual Healthcare Conference
03/04/2019
SOUTH SAN FRANCISCO, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ:CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer, will present a corporate [...]
Join Achieve TMS East to Celebrate the Grand Opening of its Woburn Location
03/04/2019
WOBURN, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- Achieve TMS East , Massachusetts’ largest provider of Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for the treatment of depression and Obsessive-Compulsive [...]
TYME Secures Capital to Advance Pivotal Studies of SM-88 in Metastatic Pancreatic Cancer
03/04/2019
Announces Closing of Registered Offering NEW YORK, April 03, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs TM ), [...]
Cutting-Edge HeartCare and AlloMap Solutions Featured at ISHLT 2019
03/04/2019
CareDx commitment to transplant innovation highlighted through seven podium and poster presentations BRISBANE, Calif., April 03, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading molecular diagnostics [...]
Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
03/04/2019
Global health implications of Nu-Med Plus’ technology fuels new overseas inquiries to potentially treat conditions including malaria, tuberculosis, COPD and neonatal respiratory issues SALT LAKE CITY, April 03, 2019 ( [...]
VBI Vaccines Announces Poster Presentation at the 7th International Congenital CMV Conference & 17th International CMV Workshop
03/04/2019
CAMBRIDGE, Mass., April 03, 2019 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, [...]
Fibrocell Announces Board Member Christine St.Clare Honored by National Association of Corporate Directors
03/04/2019
- Annual NACD Directorship 100 List Recognizes the Most Influential Corporate Governance Experts - EXTON, Pa., April 03, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on [...]
Tabula Rasa HealthCare Participates in NPA’s Spring Policy Forum
03/04/2019
Hosts Reception, Exhibits Technology and Services, and Introduces New Product for PACE MOORESTOWN, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC) , a healthcare technology [...]
Bio-Path Holdings Presents Preclinical Data at American Association for Cancer Research Annual Meeting 2019
03/04/2019
Highlighting Important Cancer Gene, STAT3, Therapeutic Strategy in Pancreatic, Non-Small Cell Lung Cancers and Acute Myelogenous Leukemia HOUSTON, April 03, 2019 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: [...]
Precipio’s HemeScreen™ Adopted by Methodist Health
03/04/2019
New Molecular Screening Assay Technology Gains Traction NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that Methodist Hospital , [...]
Genmab Announces Phase III Study Exploring Daratumumab as Maintenance Treatment in Newly Diagnosed Multiple Myeloma
03/04/2019
Company Announcement Phase III study to examine daratumumab plus lenalidomide as maintenance treatment in patients with newly diagnosed multiple myeloma Study utilizes the subcutaneous formulation of daratumumab Study [...]

Pages